Phase 3 Start
ANVS: Phase3_Start: An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Alzheimer's Disease
September 21, 2026. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 21, 2026
- Company
- Annovis Bio, Inc. (ANVS)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Start
Phase3_Start: An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Alzheimer's Disease
- Company
- Annovis Bio, Inc. (ANVS)